5 completed. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow Constriction, Pathologic: new trials by email Literature Review of Constriction, Pathologic trials Research Report on Constriction, Pathologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques Contrast-enhanced ultrasound, Shear Wave Elastography, Ultrasound Examination - Carotid Artery Plaque | Phase 2 | Completed | Mayo Clinic | 54 | 2017-11-15 | 2022-11-25 |
| Recurrent Stenoses in Arteriovenous Fistula (AVF) for Dialysis Access: CuttIng ballooN angioplaSTy Combined wITh Paclitaxel drUg coaTed Balloon Angioplasty, an observatIONal Clinical Study Cutting balloon followed by paclitaxel coated balloon - Dialysis Access Malfunction | Phase 2 | Completed | Singapore General Hospital | 44 | 2017-09-08 | 2021-08-24 |
| A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification Ataciguat (HMR1766), Placebo Comparator: Matching Placebo - Aortic Valve Stenosis | Phase 2 | Completed | Mayo Clinic | 35 | 2015-06-01 | 2021-01-22 |
| Sirolimus Use in Angioplasty for Vascular Access Extension Sirolimus - End Stage Renal Disease, Venous Stenosis | Phase 2 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 17 | 2011-12-01 | 2022-05-16 |
| Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions TAXUS Paclitaxel-Eluting Coronary Stent, Slow-Formulation, Express2 - Coronary Stenosis | Phase 2 / Phase 3 | Completed | Boston Scientific Corporation | 1108 | 2003-02-01 | 2010-08-06 |
Aortic Valve Stenosis (1) · Calcinosis (1) · Carotid Stenosis (1) · Coronary Stenosis (1) · Kidney Failure, Chronic (1)
Pathological Conditions, Anatomical (5) · Pathological Conditions, Signs and Symptoms (5) · Cardiovascular Diseases (3) · Heart Diseases (2) · Vascular Diseases (2) · Aortic Valve Disease (1) · Arterial Occlusive Diseases (1) · Brain Diseases (1) · Calcium Metabolism Disorders (1) · Carotid Artery Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Chronic Disease (1) · Coronary Disease (1) · Disease Attributes (1)
5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide (1) · Sirolimus (1)
Mayo Clinic (2) · Boston Scientific Corporation (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Singapore General Hospital (1)
United States (3) · Canada (1) · Singapore (1)
Anthony Jevnikar, MSc MD (1) · Gregg W. Stone, MD (1) · Jordan D Miller, PhD (1) · Matthew W Urban (1) · Stephen G. Ellis, MD (1)